NCT06538038 2026-03-16
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
PrECOG, LLC.
Recruiting
PrECOG, LLC.
University of Washington
Sichuan University
Krystal Biotech, Inc.
University Hospital, Essen
Sun Yat-sen University